Sepsis – Pipeline Insight, 2022: Innovations from SciClone, Sanofi, BioAegis & More Set to Transform Sepsis Treatment – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Sepsis – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This “Sepsis- Pipeline Insight, 2022” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Sepsis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … [Read more…]

Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy

TOKYO–(BUSINESS WIRE)–Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in Alpha Fusion Inc. (“AF”) (Head Office: Kita-ku, Osaka, Chief Executive Officer: Sunao Fujioka), a developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy (“TAT”). AF will aim at establishing their pipeline (*1). Development … [Read more…]

Biocytogen Announces RenLite™ Licensing Agreement with Janssen

BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (“Janssen”). Under the agreement, Biocytogen grants Janssen and its affiliates a non-exclusive worldwide license to use Biocytogen’s proprietary RenLite™ platform and underlying intellectual … [Read more…]

Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors

GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8008, an antibody-drug conjugate (ADC) that targets Trop2. The multicenter, open-label Phase 1 clinical study in patients with advanced solid tumors aims to evaluate the safety and tolerability of BAT8008. Key … [Read more…]

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Akston has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine Akston is continuing its progress to secure Emergency Use Authorization (EUA) in India and has begun working with a new CDMO to produce AKS-452   BEVERLY, Mass. and BANGALORE, India–(BUSINESS WIRE)–#VIE–Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, … [Read more…]

Japan natto cooperative society federation launched the Chinese version of its official website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” on Monday, March 6, to promote the appeal of natto to the world

TOKYO–(BUSINESS WIRE)–The Japan natto cooperative society federation (Arakawa-ku, Tokyo; Chairman: Yoshihiro Noro) has launched the Chinese version of its new website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” to promote the power of natto, a traditional Japanese food that has supported Japanese people’s health, to the world. • “Natto … [Read more…]

Japan natto cooperative society federation launched the English version of its official website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” on Monday, March 6, to promote the appeal of natto to the world

TOKYO–(BUSINESS WIRE)–The Japan natto cooperative society federation (Arakawa-ku, Tokyo; Chairman: Yoshihiro Noro) has launched its new website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” to promote the power of natto, a traditional Japanese food that has supported Japanese people’s health, to the world. • “Natto Power” official English website … [Read more…]

Mexico Needs mpox Vaccine, Says AHF and Vaccine Advocates in The Lancet Letter

MEXICO CITY–(BUSINESS WIRE)–#Mexico–Activists and public health experts in Mexico demand that officials of the Mexican Ministry of Health (SSA) and the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) authorize the use of monkeypox (mpox) vaccines in the country. “Despite the fact that mpox was declared a Public Health Emergency of International Concern by … [Read more…]

Model N Announces Proposed Offering of $220.0 Million of Convertible Senior Notes Due 2028

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), a leading provider of cloud revenue management solutions for life sciences and high tech companies, announced today that it intends to offer, subject to market conditions and other factors, $220.0 million aggregate principal amount of convertible senior notes due 2028 in a private placement to persons reasonably … [Read more…]

Miravo Healthcare™ Announces Shareholder Approval of Plan of Arrangement

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“Miravo” or the “Company”) is pleased to announce that, at today’s special meeting of shareholders (the “Meeting”), its shareholders (“Shareholders”) voted in favour of a special resolution to approve the previously announced plan of arrangement (the “Arrangement”) pursuant to which, among other things, Searchlight Pharma … [Read more…]